Home › Conferences
2026 biotech conference calendar
Every major medical and scientific conference where biotech companies present clinical data in H2 2026, dates, location, therapeutic focus, and any presenting companies we can source. Facts, not advice.
The FDA does not run these meetings, and the study behind this site finds no reliable pre-conference run-up: across 1,425 presentations the median presenter moved −0.03% in the 30 trading days before the meeting and −1.59% in the 5 days after. Every date below comes from the organiser; every presenter below links the filing or release that named the meeting. The study.
The presenter list is built from companies' own SEC filings and press releases, each row linking the document it came from. It is not the organiser's programme: abstract titles are embargoed until close to most meetings, so absence here is not absence of presentations.
35 upcoming conferences where biotech companies report clinical data, through 2027. Every date is taken from the organiser's own site, linked on each row. Where a meeting has announced itself but not its dates, it is listed at the bottom rather than given a plausible-looking date.
Oct 9 to 12, 2026
New Orleans, US · Ophthalmology and ocular gene therapy · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Oct 9 to 14, 2026
Nashville, US · Gastroenterology · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Oct 9 to 12, 2026
Boston, US · Bone and mineral · official site
ENTXEB613
1 company presentation(s) we can source to a filing or company release. This is not the full programme.
Oct 21 to 25, 2026 · in 9 days
Denver, US · Nephrology · official site
CLYMbudoprutug; CLYM116MAZEMZE829; MZE782
2 company presentation(s) we can source to a filing or company release. This is not the full programme.
Oct 21 to 23, 2026 · in 9 days
Toronto, CA · Multiple sclerosis · official site
IMUXvidofludimus calcium (IMU-838)KYTXmiv-cel (KYV-101)TGTXazer-cel; BRIUMVITLSAIntranasal foralumabZBIOorelabrutinib; obexelimab
5 company presentation(s) we can source to a filing or company release. This is not the full programme.
Oct 21 to 24, 2026 · in 9 days
Washington DC, US · Infectious disease · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Oct 23 to 27, 2026 · in 11 days
Madrid, ES · Oncology · official site
BLRXGLIX1 (with Hemispherian AS) - PRECELCgedatolisibCMPXTovecimigEIKNEIK1001, EIK1003, EIK1004, EIK1005EVAXunspecifiedIDYADarovasertib, IDE849 (SHR-4849)IMMPEftilagimod alfaIMTXAnzu-cel (IMA203), IMA203CD8, IMA4KTTAPAS-004MGNXposterMOLNposterMRNAintismeran autogene (mRNA-4157/V94NBPgivastomigNUVBIBTROZI (taletrectinib)ORICEnozertinib (ORIC-114), rinzimetosXNCRXmAb819ZLABZL-1310ZNTLAzenosertib
18 company presentation(s) we can source to a filing or company release. This is not the full programme.
Nov 4 to 8, 2026 · in 23 days
Phoenix, US · Cancer immunotherapy · official site
CADLaglatimagene besadenovec; linoserpOBXamsoki-cel (OBX-115)
2 company presentation(s) we can source to a filing or company release. This is not the full programme.
Nov 5 to 9, 2026 · in 24 days
Denver, US · Hepatology · official site
MNPRALXN1840 (tiomolibdate choline)VIRelebsiran + tobevibart
2 company presentation(s) we can source to a filing or company release. This is not the full programme.
Nov 6 to 11, 2026 · in 25 days
Orlando, US · Rheumatology · official site
2 company presentation(s) we can source to a filing or company release. This is not the full programme.
Nov 6 to 9, 2026 · in 25 days
Chicago, US · Cardiovascular · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Nov 12 to 16, 2026 · in 31 days
Phoenix, US · Allergy and immunology · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Nov 12 to 15, 2026 · in 31 days
Philadelphia, US · Neuro-oncology · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Nov 14 to 17, 2026 · in 33 days
National Harbor, US · Obesity and metabolic · official site
1 company presentation(s) we can source to a filing or company release. This is not the full programme.
Nov 16 to 19, 2026 · in 35 days
Boston, US · Alzheimer's disease · official site
CRVOpresentation
1 company presentation(s) we can source to a filing or company release. This is not the full programme.
Nov 18 to 20, 2026 · in 37 days
Barcelona, ES · Early-phase oncology · official site
APREAPR-1051 (WEE1)ERASERAS-0015
2 company presentation(s) we can source to a filing or company release. This is not the full programme.
Dec 4 to 8, 2026 · in 53 days
Denver, US · Epilepsy · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Dec 4 to 6, 2026 · in 53 days
Singapore, SG · Oncology, Asia-Pacific · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Dec 8 to 11, 2026 · in 57 days
San Antonio, US · Breast cancer · official site
1 company presentation(s) we can source to a filing or company release. This is not the full programme.
Dec 12 to 15, 2026 · in 61 days
New Orleans, US · Haematology · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Dec 14 to 16, 2026 · in 63 days
London, UK · Immuno-oncology, cell and gene therapy · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Jan 21 to 23, 2027 · in 101 days
San Francisco, US · GI oncology · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Jan 31 to Feb 4, 2027 · in 111 days
San Diego, US · Lysosomal and rare metabolic disease · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Feb 11 to 13, 2027
San Francisco, US · GU oncology · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Mar 19 to 23, 2027
San Francisco, US · Dermatology · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Apr 2 to 7, 2027
Orlando, US · Cancer research · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Apr 10 to 12, 2027
Houston, US · Cardiovascular · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
May 1 to 5, 2027
Washington DC, US · Neurology · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Philadelphia, US · Gene and cell therapy · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
May 14 to 19, 2027
New Orleans, US · Pulmonary and critical care · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
May 15 to 18, 2027
Washington DC, US · GI and hepatology · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Jun 4 to 8, 2027
Chicago, US · Oncology · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Jun 10 to 13, 2027
Barcelona, ES · Haematology · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Jun 16 to 19, 2027
London, UK · Hepatology · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Jun 18 to 21, 2027
Washington DC, US · Diabetes · official site
Presenter list not published yet. Organisers usually release abstract titles a few weeks before the meeting, and we only name a company once its own filing or release says it is presenting. We do not estimate this.
Announced but undated
- JPM J.P. Morgan Healthcare Conference 2027. J.P. Morgan has not published 2027 dates. Third-party sites claim 11 to 14 January 2027; that is unverified and is not published here. source
Questions
What does this page track?
Upcoming presentations of tracked drug programs at major medical conferences, with dates, presenting companies and sources.
Why do conference presentations matter?
Abstract acceptance is public, scheduled information about a program's data; our conference run-up study measures how stocks have behaved around 1,425 such presentations. The study.
Where do the dates come from?
Conference programs and sponsor announcements; every entry links its source.
About · Corrections · Changelog · Glossary · Methodology
Not affiliated with any conference organizer. pdufa.bio is an independent publication with no affiliation with, endorsement by, sponsorship by, or connection to the U.S. Food and Drug Administration or any other government agency. “FDA”, “PDUFA” and all company, drug and ticker names are used descriptively and remain the property of their respective owners.
Informational and educational purposes only. Not investment advice. Nothing on this page is investment, legal, tax or medical advice, or an offer or solicitation to buy or sell any security. pdufa.bio is not a registered investment adviser or broker-dealer and does not recommend trades or publish individual-drug approval probabilities. Verify every date and outcome against primary FDA, SEC or company filings. Data is provided as is, without warranty of any kind, and past behaviour does not predict future outcomes.
© 2026 pdufa.bio. All rights reserved.
Not affiliated with any conference organizer. pdufa.bio is an independent publication with no affiliation with, endorsement by, sponsorship by, or connection to the U.S. Food and Drug Administration or any other government agency. “FDA”, “PDUFA” and all company, drug and ticker names are used descriptively and remain the property of their respective owners.
Informational and educational purposes only. Not investment advice. Nothing on this page is investment, legal, tax or medical advice, or an offer or solicitation to buy or sell any security. pdufa.bio is not a registered investment adviser or broker-dealer and does not recommend trades or publish individual-drug approval probabilities. Verify every date and outcome against primary FDA, SEC or company filings. Data is provided as is, without warranty of any kind, and past behaviour does not predict future outcomes.
© 2026 pdufa.bio. All rights reserved.